SynthesisClinical neuroradiology2026
General Versus Non-General Anesthesia in Endovascular Treatment for Posterior Circulation Stroke: a Systematic Review and Meta-analysis.
Synthesis in Clinical neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis systematic review and meta-analysis aimed to compare general anesthesia (GA) versus non-GA effects on clinical and procedural outcomes during endovascular therapy (EVT) for posterior circulation stroke.
methodsFollowing PRISMA 2020, we systematically searched PubMed, Cochrane, Web of Science, Scopus, Embase until June-2025 for comparative studies on GA vs. non-GA in posterior circulation EVT. Data on 90-day mortality, intracranial hemorrhage (any, aICH; symptomatic, sICH), functional independence (modified Rankin Scale [mRS] 0‑2/0-3), and successful recanalization (mTICI 2b-3) were extracted.
resultsFourteen studies, 3899 patients (1950 GA, 1949 non-GA) were included. No significant differences between GA and non-GA were found for 90-day all-cause mortality (OR 1.23; 95% CI: 0.92-1.63), aICH (OR 0.72; 95% CI: 0.45-1.14), sICH (OR 0.79; 95% CI: 0.58-1.06), or functional independence. However, GA significantly increased the odds of successful recanalization (mTICI 2b-3) (OR 1.24; 95% CI: 1.01-1.52; p = 0.0389).
conclusionIn posterior circulation EVT, GA enhances mTICI 2b‑3 but offers no demonstrable clinical advantage or disadvantage over non-GA for mortality, aICH sICH, or functional independence. An individualized anesthetic approach, balancing procedural stability against physiological risks, is advised. Future randomized trials with optimized physiological management are crucial to align technical and clinical gains.
Indexed as
Identifiers
41746322What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.